BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8557013)

  • 41. The effect of priming with vecuronium and rocuronium on young and elderly patients.
    Aziz L; Jahangir SM; Choudhury SN; Rahman K; Ohta Y; Hirakawa M
    Anesth Analg; 1997 Sep; 85(3):663-6. PubMed ID: 9296427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The contribution of muscle relaxants to the advancement of anaesthetic practice: what is required of new compounds?
    Miller RD; von Ehrenburg W
    Eur J Anaesthesiol Suppl; 1994; 9():1-8. PubMed ID: 7925199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molar potency is not predictive of the speed of onset of atracurium.
    Kopman AF; Klewicka MM; Neuman GG
    Anesth Analg; 1999 Oct; 89(4):1046-9. PubMed ID: 10512288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intubating conditions and time course of rocuronium-induced neuromuscular block in children.
    Fuchs-Buder T; Tassonyi E
    Br J Anaesth; 1996 Sep; 77(3):335-8. PubMed ID: 8949805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rocuronium onset of action: a comparison with atracurium and vecuronium.
    Bartkowski RR; Witkowski TA; Azad S; Lessin J; Marr A
    Anesth Analg; 1993 Sep; 77(3):574-8. PubMed ID: 8103649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of intubating conditions after rocuronium or vecuronium when the timing of intubation is judged by clinical criteria.
    Smith I; Saad RS
    Br J Anaesth; 1998 Feb; 80(2):235-7. PubMed ID: 9602591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Priming with vecuronium and atracurium--a comparison.
    Mortier E; Versichelen L; Herregods L; Rolly G
    Acta Anaesthesiol Belg; 1987; 38(1):83-7. PubMed ID: 2884797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Optimum intubating dose of rocuronium for short duration surgery in adult patients].
    Isaka T; Suzuki T; Mizutani H; Fukano N; Saeki S; Ogawa S
    Masui; 2010 Feb; 59(2):160-3. PubMed ID: 20169950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new infusion design for atracurium and vecuronium.
    Ostergaard D; Engbaek J; Ording H; Viby-Mogensen J
    Eur J Anaesthesiol; 1987 Mar; 4(2):87-92. PubMed ID: 2885188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tracheal intubation conditions after one minute: rocuronium and vecuronium, alone and in combination.
    England AJ; Margarson MP; Feldman SA
    Anaesthesia; 1997 Apr; 52(4):336-40. PubMed ID: 9135185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Speed of intubation using a new neuromuscular blocker. Rocuronium bromide (ORG 9426)].
    Alvarez-Gómez JA; Fabregat J; Estellés ME; Brugger AJ; Aguilar R; Pérez F
    Rev Esp Anestesiol Reanim; 1994; 41(1):3-6. PubMed ID: 7912444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans.
    Wierda JM; Proost JH; Schiere S; Hommes FD
    Eur J Anaesthesiol Suppl; 1994; 9():66-74. PubMed ID: 7925212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action.
    Debaene B; Plaud B; Dilly MP; Donati F
    Anesthesiology; 2003 May; 98(5):1042-8. PubMed ID: 12717123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neuromuscular blocking effects of Org 9426 (rocuronium bromide); a comparative study with vecuronium bromide in Japanese patients].
    Shingu K; Masuzawa M; Omote K; Namiki A; Kikuchi H; Kawamada M; Sato S; Kimura T; Hatano N; Nakatsuka H; Morita K; Hara T; Kanmura Y; Takeda J
    Masui; 2006 Sep; 55(9):1140-8. PubMed ID: 16984012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pretreatment technique for fast intubation with vecuronium: intubation conditions and unwanted effects.
    Van Aken H; Mertes N; Hauss GM; Heinecke A; Lawin P
    Acta Anaesthesiol Belg; 1986; 37(3):199-204. PubMed ID: 2878558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the onset time and intubation conditions of rocuronium bromide in children.
    McDonald PF; Sainsbury DA; Laing RJ
    Anaesth Intensive Care; 1997 Jun; 25(3):260-1. PubMed ID: 9209607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical experiences with vecuronium in children.
    De MP; Paul AK
    J Indian Med Assoc; 1991 May; 89(5):125-7. PubMed ID: 1684200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rocuronium for rapid sequence induction in morbidly obese patients: a prospective study for evaluation of intubation conditions after administration 1.2 mg kg⁻¹ ideal body weight of rocuronium.
    Gaszynski TM; Szewczyk T
    Eur J Anaesthesiol; 2011 Aug; 28(8):609-10. PubMed ID: 21562423
    [No Abstract]   [Full Text] [Related]  

  • 59. [Rocuronium vs atracurium vs suxamethonium for double-lumen endobronchial tube intubation].
    Misiołek H; Tombarkiewicz M; Zajaczkowska-Druzba K; Rutkowska K
    Anestezjol Intens Ter; 2009; 41(2):68-72. PubMed ID: 19697822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged neuromuscular blockade in two critically ill patients treated with atracurium.
    Hoey LL; Joslin SM; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1995; 15(2):254-9. PubMed ID: 7624274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.